Display options
Share it on

Exp Ther Med. 2013 Feb;5(2):389-394. doi: 10.3892/etm.2012.814. Epub 2012 Nov 16.

Endoscopic nasobiliary drainage improves jaundice attack symptoms in benign recurrent intrahepatic cholestasis: A case report.

Experimental and therapeutic medicine

Noritaka Wakui, Mitsuru Fujita, Nobuyuki Oba, Yoshiya Yamauchi, Yuki Takeda, Nobuo Ueki, Takafumi Otsuka, Shuta Nishinakagawa, Saori Shiono, Tatsuya Kojima

Affiliations

  1. Departments of Internal Gastroenterology, Tokyo Rosai Hospital, Tokyo 143-0013, Japan.

PMID: 23403701 PMCID: PMC3570127 DOI: 10.3892/etm.2012.814

Abstract

A 66-year-old male with unbearable pruritus and jaundice was admitted for detailed examination. Blood tests on admission showed increased bilirubin with a dominant direct fraction. Ultrasonography and computed tomography performed subsequent to admission showed no narrowing or distension of the bile ducts. As the jaundice symptoms were not improved by the oral administration of ursodeoxycholic acid (300 mg/day) that had been started immediately after admission, endoscopic retrograde cholangiopancreatography (ERCP) was performed on hospital day 14. This also showed no abnormalities of the bile ducts. After considerating its potential effects for improving jaundice, endoscopic nasobiliary drainage (ENBD) was performed on the same day and was followed by immediate improvements in pruritus and jaundice. Detailed examinations were performed to identify the cause of the jaundice, which was suspected to be viral hepatitis, autoimmune hepatitis or drug-induced liver injury, however, there were no findings suggestive of any of these conditions. Following a further increase in bilirubin levels, confirmed by additional blood tests, a liver biopsy was performed. Histological findings were consistent with the histological features of benign recurrent intrahepatic cholestasis (BRIC). Although ursodeoxycholic acid is used as a first-line treatment in most cases of BRIC, ENBD should also be considered for patients not responding to this treatment.

Keywords: Sonazoid; arrival time parametric imaging; benign recurrent intrahepatic cholestasis; contrast-enhanced sonography; endoscopic nasobiliary drainage

References

  1. Am J Gastroenterol. 1998 Sep;93(9):1510-7 - PubMed
  2. Gastroenterology. 2004 Aug;127(2):379-84 - PubMed
  3. Intern Med. 2008;47(7):599-602 - PubMed
  4. Nat Genet. 1998 Mar;18(3):219-24 - PubMed
  5. J Ultrasound Med. 2012 Mar;31(3):373-82 - PubMed
  6. Lancet. 1959 Oct 31;2(7105):686-90 - PubMed
  7. Gastroenterology. 2009 Mar;136(3):1060-9 - PubMed
  8. Hepatology. 2010 Jun;51(6):2049-60 - PubMed
  9. J Clin Gastroenterol. 1989 Oct;11(5):546-51 - PubMed
  10. Clin Liver Dis. 2004 Feb;8(1):133-49, vii - PubMed
  11. Hepatology. 1999 Feb;29(2):506-8 - PubMed
  12. Hepatology. 2006 Jan;43(1):51-3 - PubMed
  13. Gastroenterology. 1976 Aug;71(2):202-7 - PubMed
  14. Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):541-53 - PubMed
  15. MedGenMed. 2004 Jun 25;6(2):61 - PubMed
  16. Acta Med Scand. 1969 Jun;185(6):523-30 - PubMed

Publication Types